NCT04911413View on ClinicalTrials.gov

Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

March 5, 2021

Study Completion Date

June 15, 2021

Conditions
Cardiac Surgical ProceduresBlood TransfusionTranexamic Acid
Interventions
DRUG

Tranexamic acid

The drug used in this RCT is tranexamic acid. We used three different doses of TXA in three groups.

Trial Locations (1)

100037

Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

NCT04911413 - Comparison of Three Tranexamic Acid Dose Regimens in Patients Undergoing Cardiac Valve Surgery | Biotech Hunter | Biotech Hunter